There were 14 deaths with influenza and pneumonia listed as the underlying cause reported in Alabama during the week ending Sept. 17, 2022, a 6.7% decrease from the previous week.
There were 33 deaths from chronic lower respiratory diseases reported in Alabama in the week ending Sept. 3, making up 5.8% of total deaths by all causes in Alabama.
There were 32 deaths from cerebrovascular diseases reported in Alabama in the week ending Sept. 3, making up 5.7% of total deaths by all causes in Alabama.
There were less than 10 deaths from diabetes mellitus reported in Alabama in the week ending Sept. 3, making up less than 1.8% of total deaths by all causes in Alabama.
There were 17 deaths from nephritis, nephrotic syndrome and nephrosis reported in Alabama in the week ending Sept. 3, making up three% of total deaths by all causes in Alabama.
There were less than 10 deaths from influenza and pneumonia reported in Alabama in the week ending Sept. 3, making up less than 1.8% of total deaths by all causes in Alabama.
There were 35 deaths with COVID-19 listed as the underlying cause reported in Alabama during the week ending Sept. 10, 2022, a 2.9% increase over the previous week.
There were 50 deaths with COVID-19 listed as a contributing cause reported in Alabama during the week ending Sept. 10, 2022, a 13.6% increase over the previous week.
There were 186 deaths with cancer listed as the underlying cause reported in Alabama during the week ending Sept. 10, 2022, a 5.1% increase over the previous week.
There were 236 deaths with heart disease listed as the underlying cause reported in Alabama during the week ending Sept. 10, 2022, a 7.5% decrease from the previous week.
There were 17 deaths with COVID-19 listed as the underlying cause reported in Alabama in the week ending Aug. 27, making up 3.2% of total deaths by all causes in Alabama.
There were 37 deaths with chronic lower respiratory disease listed as the underlying cause reported in Alabama during the week ending Sept. 10, 2022, a 19.6% decrease from the previous week.